Sergio Raposeiras-Roubín to Purinergic P2Y Receptor Antagonists
This is a "connection" page, showing publications Sergio Raposeiras-Roubín has written about Purinergic P2Y Receptor Antagonists.
Connection Strength
0.307
-
Assessing the performance of the PRECISE-DAPT and PARIS risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients. EuroIntervention. 2018 03 20; 13(16):1914-1922.
Score: 0.155
-
Association Between Ischemic and Bleeding Risk Scores and the Use of New P2Y12 Inhibitors in Patients With Acute Coronary Syndrome. Rev Esp Cardiol (Engl Ed). 2018 Jul; 71(7):538-544.
Score: 0.152